Long-term pharmacological therapy of Brugada syndrome: Is J-wave attenuation a marker of drug efficacy?

23Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

We herein describe two patients with Brugada syndrome in whom J-waves were successfully modified by drugs. Case 1 was a 54-year-old man who presented with repeated ventricular fibrillations (VF) and J-point elevation in the right precordial and lateral leads. After administration of cilostazol (200 mg/d), J-waves disappeared and coved-type ST-segment elevation changed to a saddleback-type for 25 months. Case 2 was a 31-year-old man who presented with a VF storm and J-point elevation in the lateral leads. After administration of quinidine (300 mg/d), J-waves and coved-type ST-segment elevation disappeared for 20 months. Jwave disappearance and coved-type ST-segment elevation were followed by VF suppression, probably due to transient outward potassium current (I to) suppression. © 2014 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Hasegawa, K., Ashihara, T., Kimura, H., Jo, H., Itoh, H., Yamamoto, T., … Horie, M. (2014). Long-term pharmacological therapy of Brugada syndrome: Is J-wave attenuation a marker of drug efficacy? Internal Medicine, 53(14), 1523–1526. https://doi.org/10.2169/internalmedicine.53.1829

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free